loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X

Technical details about Lutetium Chloride Lu-177, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: Lutetium (177lu) chloride, 16434-14-3, Lutetium chloride (177lucl3), 1u477369sn, Endolucinbeta, Lumark
Molecular Formula
Cl3Lu
Molecular Weight
283.30  g/mol
InChI Key
AEDROEGYZIARPU-SUNKFXMWSA-K
FDA UNII
1U477369SN

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
lutetium-177(3+);trichloride
2.1.2 InChI
InChI=1S/3ClH.Lu/h3*1H;/q;;;+3/p-3/i;;;1+2
2.1.3 InChI Key
AEDROEGYZIARPU-SUNKFXMWSA-K
2.1.4 Canonical SMILES
[Cl-].[Cl-].[Cl-].[Lu+3]
2.1.5 Isomeric SMILES
[Cl-].[Cl-].[Cl-].[177Lu+3]
2.2 Other Identifiers
2.2.1 UNII
1U477369SN
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Lutetium (177lu) Chloride

2. 16434-14-3

3. Lutetium Chloride (177lucl3)

4. 1u477369sn

5. Endolucinbeta

6. Lumark

7. Unii-1u477369sn

8. Endolucinbeta (tn)

9. Lutetium (177 Lu) Chloride

10. Lutetium-177 Chloride

11. Dtxsid20167745

12. Lutetium-177 Trichloride

13. Lutetium (177lu) Chloride [who-dd]

14. D10828

15. Q27252884

2.4 Create Date
2013-07-08
3 Chemical and Physical Properties
Molecular Weight 283.30 g/mol
Molecular Formula Cl3Lu
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count0
Exact Mass281.85032 g/mol
Monoisotopic Mass281.85032 g/mol
Topological Polar Surface Area0 Ų
Heavy Atom Count4
Formal Charge0
Complexity0
Isotope Atom Count1
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count4
4 Drug and Medication Information
4.1 Drug Indication

EndolucinBeta is a radiopharmaceutical precursor, and it is not intended for direct use in patients. It is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with Lutetium (177Lu) chloride.


Lumark is a radiopharmaceutical precursor. It is not intended for direct use in patients. This medicinal must be used only for the radiolabelling of carrier molecules, which have been specifically developed and authorised for radiolabelling with this radionuclide.


Radiolabelling agent


ilLuzyce is a radiopharmaceutical precursor, and it is not intended for direct use in patients. It is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177Lu) chloride.


5 Pharmacology and Biochemistry
5.1 ATC Code

V10X


V10


V10X


Post Enquiry
POST ENQUIRY